A	O
meta-analysis	B:C0920317
on	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
in	O
depression	O
therapy	O
in	O
comparison	O
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
adults	O
.	O

A	O
meta-analysis	O
on	O
the	O
efficacy	O
and	O
safety	O
of	O
St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
in	O
depression	O
therapy	O
in	O
comparison	O
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
adults	O
.	O

A	O
meta-analysis	O
on	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
in	O
depression	B:C0011570
therapy	O
in	O
comparison	O
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
adults	O
.	O

A	O
meta-analysis	O
on	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
in	O
depression	O
therapy	B:C0087111
in	O
comparison	O
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
adults	O
.	O

A	O
meta-analysis	O
on	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
in	O
depression	O
therapy	O
in	O
comparison	O
with	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
adults	O
.	O

The	O
aim	O
of	O
the	O
study	B:C2603343
was	O
to	O
investigate	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
)	O
in	O
the	O
treatment	O
of	O
depression	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
efficacy	O
and	O
safety	O
of	O
St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
)	O
in	O
the	O
treatment	O
of	O
depression	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
)	O
in	O
the	O
treatment	O
of	O
depression	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
)	O
in	O
the	O
treatment	O
of	O
depression	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
efficacy	O
and	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
)	O
in	O
the	O
treatment	O
of	O
depression	B:C0011570
.	O

Databases	B:C0242356
were	O
searched	O
for	O
studies	O
comparing	O
efficacy	O
and	O
/	O
or	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
depression	O
from	O
1966	O
to	O
April	O
2015	O
.	O

Databases	O
were	O
searched	O
for	O
studies	B:C0681814
comparing	O
efficacy	O
and	O
/	O
or	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
depression	O
from	O
1966	O
to	O
April	O
2015	O
.	O

Databases	O
were	O
searched	O
for	O
studies	O
comparing	O
efficacy	O
and	O
/	O
or	O
safety	O
of	O
St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
depression	O
from	O
1966	O
to	O
April	O
2015	O
.	O

Databases	O
were	O
searched	O
for	O
studies	O
comparing	O
efficacy	O
and	O
/	O
or	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
with	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
depression	O
from	O
1966	O
to	O
April	O
2015	O
.	O

Databases	O
were	O
searched	O
for	O
studies	O
comparing	O
efficacy	O
and	O
/	O
or	O
safety	O
of	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
with	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
depression	B:C0011570
from	O
1966	O
to	O
April	O
2015	O
.	O

Stata	B:C0037585
software	I:C0037585
was	O
used	O
for	O
statistical	O
analysis	O
.	O

Twenty	O
-	O
seven	O
studies	B:C0681814
met	O
the	O
study	O
entry	O
criteria	O
.	O

Twenty	O
-	O
seven	O
studies	O
met	O
the	O
study	B:C2603343
entry	O
criteria	O
.	O

A	O
total	O
of	O
3,126	O
patients	O
with	O
depression	B:C0011570
were	O
included	O
.	O

St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
did	O
not	O
differ	O
from	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
clinical	O
response	I:C4055223
,	O
remission	O
,	O
and	O
mean	O
reduction	O
in	O
Hamilton	O
Rating	I:C0451203
Scale	I:C0451203
for	I:C0451203
Depression	I:C0451203
score	I:C0451203
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
did	O
not	O
differ	O
from	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
clinical	O
response	I:C4055223
,	O
remission	O
,	O
and	O
mean	O
reduction	O
in	O
Hamilton	O
Rating	I:C0451203
Scale	I:C0451203
for	I:C0451203
Depression	I:C0451203
score	I:C0451203
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
did	O
not	O
differ	O
from	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
clinical	B:C4055223
response	I:C4055223
,	O
remission	O
,	O
and	O
mean	O
reduction	O
in	O
Hamilton	O
Rating	I:C0451203
Scale	I:C0451203
for	I:C0451203
Depression	I:C0451203
score	I:C0451203
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
did	O
not	O
differ	O
from	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
clinical	O
response	I:C4055223
,	O
remission	B:C0544452
,	O
and	O
mean	O
reduction	O
in	O
Hamilton	O
Rating	I:C0451203
Scale	I:C0451203
for	I:C0451203
Depression	I:C0451203
score	I:C0451203
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
did	O
not	O
differ	O
from	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
in	O
clinical	O
response	I:C4055223
,	O
remission	O
,	O
and	O
mean	O
reduction	O
in	O
Hamilton	B:C0451203
Rating	I:C0451203
Scale	I:C0451203
for	I:C0451203
Depression	I:C0451203
score	I:C0451203
.	O

St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
had	O
a	O
significantly	O
lower	O
rate	O
of	O
adverse	O
events	I:C0877248
compared	O
to	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
summary	O
relative	O
risk	O
:	O
0.77	O
;	O
95	O
%	O
confidence	O
interval	O
:	O
0.70	O
,	O
0.84	O
,	O
P=0.00	O
)	O
and	O
had	O
fewer	O
withdrawals	O
due	O
to	O
adverse	O
events	I:C0877248
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
had	O
a	O
significantly	O
lower	O
rate	O
of	O
adverse	B:C0877248
events	I:C0877248
compared	O
to	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
summary	O
relative	O
risk	O
:	O
0.77	O
;	O
95	O
%	O
confidence	O
interval	O
:	O
0.70	O
,	O
0.84	O
,	O
P=0.00	O
)	O
and	O
had	O
fewer	O
withdrawals	O
due	O
to	O
adverse	O
events	I:C0877248
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
had	O
a	O
significantly	O
lower	O
rate	O
of	O
adverse	O
events	I:C0877248
compared	O
to	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
summary	O
relative	O
risk	O
:	O
0.77	O
;	O
95	O
%	O
confidence	O
interval	O
:	O
0.70	O
,	O
0.84	O
,	O
P=0.00	O
)	O
and	O
had	O
fewer	O
withdrawals	O
due	O
to	O
adverse	O
events	I:C0877248
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
had	O
a	O
significantly	O
lower	O
rate	O
of	O
adverse	O
events	I:C0877248
compared	O
to	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
(	O
summary	O
relative	O
risk	O
:	O
0.77	O
;	O
95	O
%	O
confidence	O
interval	O
:	O
0.70	O
,	O
0.84	O
,	O
P=0.00	O
)	O
and	O
had	O
fewer	O
withdrawals	O
due	O
to	O
adverse	B:C0877248
events	I:C0877248
.	O

St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
had	O
superior	O
safety	O
in	O
the	O
management	O
of	O
patients	O
with	O
depression	O
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
had	O
superior	O
safety	O
in	O
the	O
management	O
of	O
patients	O
with	O
depression	B:C0011570
.	O

Both	O
St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
are	O
effective	O
in	O
treating	O
mild	O
-	O
to	O
-	O
moderate	O
depression	O
.	O

Both	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
are	O
effective	O
in	O
treating	O
mild	O
-	O
to	O
-	O
moderate	O
depression	O
.	O

Both	O
St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
and	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
are	O
effective	O
in	O
treating	O
mild	O
-	O
to	O
-	O
moderate	O
depression	B:C0011570
.	O

St	B:C0813171
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
is	O
safer	O
than	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
is	O
safer	B:C0243095
than	O
selective	O
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
.	O

St	O
John	I:C0813171
's	I:C0813171
wort	I:C0813171
extract	I:C0813171
is	O
safer	O
than	O
selective	B:C0360105
serotonin	I:C0360105
reuptake	I:C0360105
inhibitors	I:C0360105
.	O

